Oxford, Serum Institute Of India Launch Human Trials Of New Ebola Vaccine
The Phase I clinical trial will take place in Oxford and involve 50 healthy volunteers between the ages of 18 and 55. The goal of this first-stage study is to check whether the vaccine is safe and...
\